In Situ Hybridization Market By Technology, Probe Type, Product Type, Application & Region | Forecast 2022 to 2032
收藏www.futuremarketinsights.com2025-03-25 收录
下载链接:
https://www.futuremarketinsights.com/reports/in-situ-hybridization-market
下载链接
链接失效反馈官方服务:
资源简介:
<p>Newly-released In Situ Hybridization industry analysis report by Future Market Insights reveals that global sales of In Situ Hybridization in 2021 were held at US$ 1.3 billion. With a 10.6% CAGR, the market is projected to reach a valuation of US$ 3.9 billion by 2032. Fluorescent In Situ Hybridization (FISH) is expected to be the highest revenue-generating technology, accounting for an absolute dollar opportunity of nearly US$ 2.5 billion from 2022 to 2032.</p><table><tbody><tr><th scope='row'>Attribute</th><td>Details</td></tr><tr><th scope='row'>Global In Situ Hybridization Market (2022)</th><td>US$ 1.4 billion</td></tr><tr><th scope='row'>Global In Situ Hybridization Market (2032)</th><td>US$ 3.9 billion</td></tr><tr><th scope='row'>Global In Situ Hybridization Market CAGR (2022 to 2032)</th><td>10.6%</td></tr><tr><th scope='row'>The USA In Situ Hybridization Market CAGR (2022 to 2032) </th><td>10.8%</td></tr><tr><th scope='row'>Key Companies Profiled</th><td><ul><li>Merck KGaA</li><li>Thermo Fisher Scientific</li><li>Agilent Technologies</li><li>PerkinElmer</li><li>Leica Biosystems Nussloch GmbH</li><li>BIO VIEW</li><li>NeoGenomics Laboratories, Inc.</li><li>Bio-Rad Laboratories, Inc.</li><li>Oxford Gene Technology</li><li>Advanced Cell Diagnostics, Inc.</li></ul></td></tr></tbody></table>
<p>由未来市场洞察力公司最新发布的现场杂交产业分析报告显示,2021年全球现场杂交产品的销售额达到13亿美元。预计在未来十年,即2022年至2032年期间,市场将以10.6%的复合年增长率发展,届时市场规模有望达到39亿美元。荧光现场杂交技术(FISH)预计将成为收益最高的技术,从2022年至2032年,将为市场带来近25亿美元的绝对美元机会。</p><table><tbody><tr><th scope='row'>属性</th><td>详细信息</td></tr><tr><th scope='row'>全球现场杂交市场(2022年)</th><td>13亿美元</td></tr><tr><th scope='row'>全球现场杂交市场(2032年)</th><td>39亿美元</td></tr><tr><th scope='row'>全球现场杂交市场复合年增长率(2022年至2032年)</th><td>10.6%</td></tr><tr><th scope='row'>美国现场杂交市场复合年增长率(2022年至2032年)</th><td>10.8%</td></tr><tr><th scope='row'>主要公司简介</th><td><ul><li>默克集团</li><li>赛默飞世尔科技公司</li><li>安捷伦科技公司</li><li>珀金埃尔默公司</li><li>莱卡生物系统努斯洛赫有限公司</li><li>BIO VIEW</li><li>NeoGenomics 实验室公司</li><li>生物雷达实验室公司</li><li>牛津基因技术公司</li><li>先进细胞诊断公司</li></ul></td></tr></tbody></table>
提供机构:
www.futuremarketinsights.com



